Neurocrine Biosciences (NBIX) reported a net loss of $24.0 million, or $0.28 loss per share, compared to a net loss of $13.4 million, or $0.18 loss per share, for the same period in 2014. For the six months ended June 30, 2015, the Company reported a net loss of $25.2… Read More
Archive
Filter
Neurocrine Biosciences (NBIX) reported a net loss of $24.0 million, or $0.28 loss per share, compared to a net loss of $13.4 million, or $0.18 loss per share, for the same period in 2014. For the six months ended June 30, 2015, the Company reported a net loss of $25.2… Read More
Last Thursday’s visit by the Pope to the home of Wall Street was not enough to keep the stock market out of negative territory, though he can hardly be blamed for the multitude of sins afflicting the global financial market. As if Europe’s faltering economy wasn’t already fragile enough, news that German… Read More
[from the Portfolio Update in today’s issue of Smart Tech Investor]I am adding Dyax Corp. (DYAX) to the STI Medical Profits Portfolio because it is very close to having a real shot for FDA approval for a drug (DX-2390) that treats Hereditary Angioedema, a genetic disorder that occurs in… Read More
[from the Portfolio Update in today’s issue of Smart Tech Investor]I am adding Dyax Corp. (DYAX) to the STI Medical Profits Portfolio because it is very close to having a real shot for FDA approval for a drug (DX-2390) that treats Hereditary Angioedema, a genetic disorder that occurs in… Read More
[from today’s Portfolio Update in Smart Tech Investor]I am adding Tableau Software (DATA) to the Next Wave Portfolio because it’s one of the key beneficiaries of the shifting BI market. Tableau’s analytics software for data visualization is increasingly being implemented across all sizes of organizations. The company’s customer… Read More
[from today’s Portfolio Update in Smart Tech Investor]I am adding Tableau Software (DATA) to the Next Wave Portfolio because it’s one of the key beneficiaries of the shifting BI market. Tableau’s analytics software for data visualization is increasingly being implemented across all sizes of organizations. The company’s customer… Read More
- September 21, 2015
-
Download Issue
In this issue:The Big Picture: Biotech Sector Nears Major Decision PointIn Depth: New EBIS Pick – DYAX Corp (DYAX) – High Risk, High PotentialEBIS Portfolio Alerts: Alert: EBIS Portfolio Pricing Updates News Update: New FDA Commissioner Nominee Could Foster New Climate at AgencyThe Big Picture: Is The Biotech Sector Heading… Read More
- September 21, 2015
-
Download Issue
Businesses these days are spending more money on analytics software because they realize there are a lot of strategic insights that can be gleaned from all of their data. The overall business intelligence (BI) analytics software market, expected to grow about 9% annually over the next few years, is going… Read More
- September 21, 2015
-
Download Issue
The $50-billion global business communications market is ripe for disruption from the cloud. Older on-premise phone communications systems no longer meet the needs of a highly mobile and distributed workforce. People simply aren’t tethered to their desks anymore, so organizations need to adapt by changing the way they enable workers… Read More